Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Association between copy-number alteration of +20q, −14q and −18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma

Fig. 4

−18q and sensitivity to Cabozantinib and Sorafenib. Reproduced from TCGA, shown were a overall survival, b progression-free survival and c clinicopathological parameters of patient with and without +20q; Gene enrichment and functional annotation analysis in TCGA cases with or without +20q using the d NET-GE and e GSEA platforms with genes of interest shown in heatmap; f Reproduced from TCGA dataset, shown was correlation between copy number against corresponding mRNA expression of the gene of interest; g Reproduced from TCGA and Human Protein Atlas dataset, shown was overall survival of patients with higher and lower ARHGAP28 expression with automatically designated cutoff value

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us